Enliven Therapeutics Inc.

NASDAQ: ELVN · Real-Time Price · USD
23.65
1.74 (7.94%)
At close: Jun 16, 2025, 3:07 PM

Enliven Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ELVN stock have an median target of 40, with a low estimate of 37 and a high estimate of 42. The median target predicts an increase of 69.13% from the current stock price of 23.65.

Target Low Average Median High
Price 37 39.67 40 42
Change 56.45% 67.74% 69.13% 77.59%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating on Enli... Unlock content with Pro Subscription

Updated May 15, 2025

Rating Oct 24 Nov 24 Dec 24 Mar 25 May 25 Jun 25
Strong Buy 000110
Buy 211012
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 1 1 2 2

Financial Forecast this Year

Revenue This Year
7.14K
from 0
Increased by -%
Revenue Next Year
7.14K
from 7.14K
Increased by 0.0%
EPS This Year
-2.39
from -1.89
Increased by -26.5%
EPS Next Year
-2.8
from -2.39
Increased by -17.2%